No definition available.
Slow fetal growth and fetal malnutrition
P16_SLOW_FETAL_GROWTH_FETAL_MALNUTRITION
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
218 |
4. Check minimum number of eventsNone |
218 |
5. Include endpointsNone |
218 |
6. Filter based on genotype QC (FinnGen only) |
218 |
Control definitions (FinnGen only)
- Control exclude
- P16_DISORD_RELATED_LENGTH_GESTATION_FETAL_GROWTH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P0[5-8]
- Name in latin
- Crescentia tarda et malnutritio fetalis
Similar endpoints
↥List of similar endpoints to
Slow fetal growth and fetal malnutrition
based on the number of shared cases.
Similar with more cases:
- Disorders related to length of gestation and fetal growth
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 12946 | 6759 | 6182 |
| Only index persons | 6781 | 3568 | 3213 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.18 | 0.19 | 0.17 |
| Only index persons | 0.13 | 0.13 | 0.12 |
| Median age at first event (years) | |||
| Whole population | 0.01 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 218 | 135 | 83 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.04 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 191
- Matched controls
- 1910
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P05.1
ICD-10 Finland
Small for gestational age
+∞
140.5
117
*
P07.3
ICD-10 Finland
Other preterm infants
+∞
92.4
81
*
P05.0
ICD-10 Finland
Light for gestational age
+∞
86.1
76
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
48.5
77.8
95
38
P07.11
ICD-10 Finland
Other low birth weight 1500-1999 g
+∞
35.5
33
*
P07.12
ICD-10 Finland
Other low birth weight 2000-2499 g
+∞
35.5
33
*
E34.31
ICD-10 Finland
Short stature, prenatal disorder
30.4
25.0
33
13
602
Kela drug reimbursment
Children's severe malnutrition
12.5
24.8
46
47
P00.0
ICD-10 Finland
Fetus and newborn affected by maternal hypertensive disorders
34.0
18.8
24
8
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
+∞
16.9
16
*
P07.2
ICD-10 Finland
Extreme immaturity
+∞
16.9
16
*
P70.4
ICD-10 Finland
Other neonatal hypoglycaemia
13.5
16.2
28
24
JAB00
NOMESCO Finland
Division and ligature of inguinal hernia sac
12.9
13.7
24
21
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
+∞
13.7
13
*
P01.5
ICD-10 Finland
Fetus and newborn affected by multiple pregnancy
150.2
13.6
14
*
WX722
NOMESCO Finland
PEEP
11.7
12.1
22
21
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
11.1
11.9
22
22
P59.0
ICD-10 Finland
Neonatal jaundice associated with preterm delivery
24.8
11.8
16
7
P07.1
ICD-10 Finland
Other low birth weight
+∞
11.6
11
*
H35.1
ICD-10 Finland
Retinopathy of prematurity
+∞
11.6
11
*
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
5.5
11.3
34
72
P07.10
ICD-10 Finland
Other low birth weight 1000-1499 g
+∞
10.5
10
*
P29.30
ICD-10 Finland
Delayed closure of the ductus arteriosus
52.4
8.8
10
*
P07.01
ICD-10 Finland
Extremely low birth weight 500-749 g
+∞
8.4
8
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.9
8.2
34
100
Z3229
NOMESCO Finland
Other healthcare associate professional
3.3
8.1
44
159
RK312
NOMESCO Finland
NA
23.2
8.1
11
5
Z38.3
ICD-10 Finland
Twin, born in hospital
46.9
7.8
9
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
7.7
74
381
ZXD10
NOMESCO Finland
Scheduled procedure
2.4
7.7
87
491
R62.0
ICD-10 Finland
Delayed milestone
3.9
7.6
31
90
H01AC01
ATC
somatropin; parenteral
5.4
7.6
22
45
WX730
NOMESCO Finland
Conventional respirator
14.1
7.5
12
9
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
11.5
7.4
13
12
Z3231
NOMESCO Finland
Registered nurse
2.3
7.4
97
586
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.6
7.3
58
270
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.3
7.2
39
139
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
6.9
64
320
R4110
NOMESCO Finland
Physiotherapy
2.5
6.8
65
329
Z3226
NOMESCO Finland
Physiotherapist
2.4
6.6
68
360
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
6.4
55
262
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
6.3
57
281
K40.3
ICD-10 Finland
Unilateral or unspecified inguinal hernia, with obstruction, without gangrene
+∞
6.3
6
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
6.1
76
437
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
6.1
39
159
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
10
19
5.42
5.03
2.4
1.4
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
8
7
11.70
4.80
1.3
1.7
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
10
20
5.15
4.77
2.7
1.6
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
16
50
3.34
4.37
5.3
6.5
ug/l
2.1
2.5
0.26
16
50
(3009214) Lutropin [Units/volume] in Serum or Plasma
35
167
2.28
4.34
2.8
2.5
u/l
4.6
5.5
0.45
20
98
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
9
16
5.77
3.67
2.3
1.7
mg/l
2.0
6.2
—
9
11
(3005322) IgE [Units/volume] in Serum or Plasma
41
233
1.92
3.21
1.7
1.5
u/ml
99.4
366.7
1.79
34
222
(3021960) Folate [Moles/volume] in Serum or Plasma
32
171
2.00
2.99
1.5
1.3
nmol/l
21.3
19.3
0.23
27
146
(3023323) Follitropin [Units/volume] in Serum or Plasma
28
149
1.99
2.65
3.2
2.5
iu/l
9.0
6.4
0.34
19
94
(3014576) Chloride [Moles/volume] in Serum or Plasma
28
150
1.98
2.60
23.6
14.9
mmol/l
106.1
105.6
0.32
28
150
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
163
1396
1.63
2.50
4.2
3.7
mu/l
2.4
2.0
2.20
154
1302
(3014148) Varicella zoster virus Ab [Titer] in Serum
14
58
2.49
2.38
1.2
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
9
28
3.28
2.31
2.0
2.8
%
18.0
17.1
—
9
16
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
81
2.17
2.14
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
81
2.17
2.14
1.2
1.4
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
6
15
4.05
2.03
7.5
5.9
mmol/l
1.6
1.6
—
6
15
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
15
4.05
2.03
6.3
8.0
—
—
—
0
0
(4010399)
17
84
2.09
1.97
1.5
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
186
1679
1.69
1.96
8.3
8.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
109
885
1.44
1.92
4.9
5.0
u/l
137.2
134.1
0.13
103
831
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
189
1716
1.71
1.91
10.4
11.7
mg/l
22.6
23.8
0.18
124
1139
(3021901) Oxygen saturation in Capillary blood
10
40
2.55
1.83
3.7
10.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
73
2.11
1.81
1.1
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
35
2.61
1.80
4.7
6.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
13
3.87
1.71
1.8
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
13
3.87
1.71
1.8
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
13
3.87
1.71
1.8
1.2
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
6
19
3.19
1.65
1.3
1.5
—
15.9
—
0
7
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
14
69
2.08
1.65
16.3
19.8
%
0.7
0.7
0.05
14
69
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
14
70
2.05
1.59
16.3
19.5
%
1.0
1.0
0.11
14
70
(3014007) Fractional oxyhemoglobin in Arterial blood
14
70
2.05
1.59
16.3
19.5
%
96.0
95.4
0.16
14
70
(3015235) Bicarbonate [Moles/volume] in Capillary blood
14
70
2.05
1.59
11.1
11.8
mmol/l
23.3
22.7
0.33
14
65
(3035637) Corticotropin [Mass/volume] in Plasma
18
99
1.87
1.59
1.7
1.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
14
71
2.02
1.54
16.3
18.9
mmol/l
22.8
24.2
0.92
14
71
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
6
21
2.88
1.50
5.0
6.6
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
6
21
2.88
1.50
3.7
6.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
99
820
1.36
1.43
16.1
15.0
mmol/l
1.2
1.2
0.01
93
782
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
16
3.14
1.43
1.4
1.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
130
1124
1.37
1.43
7.9
12.5
e9/l
0.2
0.2
0.23
110
928
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
145
1276
1.38
1.42
3.8
3.3
pmol/l
14.5
14.4
0.13
134
1139
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
101
842
1.35
1.39
14.3
13.5
mmol/l
1.2
1.2
0.08
92
781
(3019150) Specific gravity of Urine by Refractometry
46
336
1.45
1.38
5.1
2.8
kg/l
1.0
1.0
0.46
11
61
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
23
2.63
1.36
10.7
11.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
42
303
1.46
1.34
1.5
1.4
pmol/l
97.2
99.0
0.09
16
153
(3013512) EKG study
25
161
1.61
1.32
2.3
2.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
63
493
1.38
1.28
7.8
9.8
g/l
38.7
37.6
0.98
63
471
(3029937) Albumin [Presence] in Urine by Test strip
44
324
1.43
1.26
5.8
3.4
estimate
0.0
0.0
—
8
114
(42870588) Differential panel, method unspecified - Blood
102
869
1.31
1.16
7.8
12.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
13
72
1.84
1.15
1.7
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
79
924
0.76
1.13
1.8
2.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
72
851
0.76
1.11
2.0
1.9
u/ml
11.9
3.6
0.78
15
140
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
21
2.39
1.08
1.2
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
80
665
1.30
1.07
6.2
11.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
20
129
1.59
1.06
2.7
3.6
mg/l
72.6
151.3
0.74
15
106
(3024891) Influenza virus A+B Ag [Presence] in Specimen
19
121
1.61
1.06
1.1
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
9
46
1.98
1.04
2.8
4.0
umol/l
26.9
24.3
—
9
46
(3018418) pH of Serum or Plasma
42
318
1.38
1.04
4.3
3.4
ph
7.4
7.4
—
7
55
(40765089) Chromosome analysis panel - Blood by G-banded
7
34
2.07
1.03
1.0
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
192
1805
1.47
1.02
16.2
17.0
%
39.6
38.7
1.56
174
1637
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
278
0.65
1.01
2.3
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
28
0.00
0.98
0.0
1.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
131
1171
1.27
0.96
9.1
13.1
e9/l
3.5
3.4
0.23
109
947
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
10
54
1.88
0.96
1.4
1.4
umol/l
4.2
3.5
—
10
48
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
193
0.59
0.95
1.8
1.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
0
32
0.00
0.95
0.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
87
741
1.27
0.95
3.5
2.9
mmol/mol
35.3
36.3
0.40
80
695
(3027944) Amphetamines [Presence] in Urine
16
239
0.64
0.94
1.4
1.8
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
6
27
2.24
0.94
4.7
4.9
kpa
9.3
9.2
—
6
27
(3013290) Carbon dioxide [Partial pressure] in Blood
6
27
2.24
0.94
4.7
4.9
kpa
5.3
4.8
—
6
27
(3015736) pH of Urine
66
545
1.29
0.91
4.7
3.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
28
2.16
0.91
1.2
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
55
1.84
0.91
1.5
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
32
237
1.40
0.91
2.2
1.6
—
—
—
0
0
(3020891) Body temperature
6
30
2.01
0.87
15.2
8.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
44
1.83
0.86
2.0
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
11
64
1.74
0.85
6.7
4.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
9
148
0.59
0.82
1.0
1.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
78
666
1.25
0.82
4.4
3.5
nmol/l
74.5
68.2
0.93
70
627
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.2
—
36.9
—
0
24
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.1
—
4.2
—
0
15
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
54
443
1.28
0.78
5.2
3.0
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
8
48
1.68
0.78
17.9
5.9
%
61.9
61.6
—
8
48
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
29
217
1.37
0.78
2.4
2.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
51
416
1.28
0.78
4.6
3.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
51
416
1.28
0.78
2.5
4.1
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.1
—
12.1
—
0
17
(3023103) Potassium [Moles/volume] in Serum or Plasma
163
1515
1.27
0.77
14.2
14.3
mmol/l
4.0
3.9
0.29
158
1451
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
23
2.18
0.76
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
23
2.18
0.76
1.6
2.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
45
363
1.29
0.75
2.4
3.9
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
24
2.09
0.74
1.2
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
16
226
0.68
0.74
1.7
1.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
66
561
1.24
0.71
3.8
4.5
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
5
26
1.93
0.70
2.8
3.2
—
250.5
—
0
6
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14
93
1.53
0.69
2.1
2.7
pmol/l
5.2
5.3
0.11
14
84
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
91
0.53
0.68
1.0
1.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
121
1098
1.21
0.68
7.4
11.2
e9/l
0.0
0.0
0.61
102
880
(40760892) CBC W Ordered Manual Differential panel - Blood
40
323
1.28
0.66
4.6
5.1
—
—
—
0
0
(44813793)
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
28
1.79
0.66
2.8
2.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
5
28
1.79
0.66
2.0
2.8
umol/l
11.9
12.3
—
5
28
(4062490)
7
44
1.60
0.65
2.1
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
78
681
1.21
0.65
4.9
3.4
estimate
0.0
0.0
—
6
112
(3001604) Monocytes [#/volume] in Blood
121
1102
1.20
0.64
7.4
11.2
e9/l
0.6
0.6
0.00
102
884
(3028300) Cannabinoids [Presence] in Urine
18
241
0.72
0.63
1.6
1.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
203
1955
1.45
0.63
16.2
17.7
e9/l
281.2
274.5
0.60
196
1843
(3027008) Opiates [Presence] in Urine
18
240
0.72
0.62
1.6
1.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
11
71
1.56
0.61
1.5
3.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
18
239
0.72
0.61
1.6
1.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
19
0.00
0.60
0.0
1.2
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
19
0.00
0.60
0.0
1.1
—
1.8
—
0
10
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
19
0.00
0.60
0.0
1.4
—
21.0
—
0
5
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
19
0.00
0.60
0.0
1.4
—
19.8
—
0
6
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
19
0.00
0.60
0.0
8.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
119
1086
1.19
0.60
7.9
11.4
%
8.1
8.3
0.28
111
1043
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
2.8
—
53.7
—
0
22
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
21.0
—
0
14
(3022229) Phosphate [Moles/volume] in Urine
6
35
1.72
0.58
3.8
2.9
mmol/l
23.1
16.9
—
6
35
(4035726)
5
86
0.57
0.57
1.0
1.9
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
203
1959
1.42
0.57
16.1
17.6
e12/l
4.7
4.6
2.81
195
1840
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
56
479
1.21
0.57
9.4
9.6
mmol/l
0.9
0.9
0.02
39
348
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
36
1.67
0.57
1.0
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
12
169
0.69
0.56
2.7
2.0
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
203
1960
1.41
0.56
16.2
17.6
e9/l
7.0
6.9
0.44
197
1841
(3024980) IgG subclass 4 [Mass/volume] in Serum
9
59
1.53
0.55
1.9
1.7
g/l
0.4
0.7
—
9
50
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
60
1.51
0.55
21.8
19.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
65
1.55
0.54
1.9
4.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
156
0.68
0.54
1.1
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
9
133
0.66
0.53
1.8
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
77
683
1.18
0.53
6.5
5.0
estimate
0.0
0.0
—
8
119
(3022096) Basophils/100 leukocytes in Blood
115
1056
1.17
0.51
7.4
11.5
%
0.5
0.6
0.98
107
1018
(3024928) Oxygen saturation in Venous blood
9
64
1.41
0.51
37.2
23.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
41
476
0.82
0.51
2.1
2.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
117
1078
1.16
0.50
7.6
11.4
%
2.8
3.2
1.22
109
1033
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
23
180
1.30
0.49
2.5
2.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
153
0.70
0.49
2.5
1.8
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
7
45
1.56
0.49
2.1
1.3
g/l
0.5
0.4
—
7
36
(3027135) IgG subclass 1 [Mass/volume] in Serum
7
45
1.56
0.49
2.1
1.3
g/l
5.7
6.3
—
7
38
(3028192) IgG subclass 2 [Mass/volume] in Serum
7
45
1.56
0.49
2.1
1.3
g/l
1.6
2.3
—
7
38
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
10
67
1.50
0.49
2.8
3.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
10
67
1.50
0.49
1.3
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
67
1.50
0.49
2.9
2.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
77
688
1.17
0.48
4.9
3.4
estimate
0.0
0.0
—
8
117
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
11
152
0.70
0.48
2.7
1.8
u/ml
133.0
153.4
—
6
65
(3011648) Oxygen content in Venous blood
7
47
1.49
0.47
43.0
28.9
%
12.6
11.6
—
7
47
(3008898) HLA-B27 [Presence]
5
80
0.61
0.46
1.0
1.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
122
1133
1.15
0.45
7.5
11.0
%
36.3
36.2
0.04
114
1094
(3045462) Protein/Creatinine [Ratio] in Urine
7
50
1.40
0.45
9.9
8.5
g/mol
29.6
93.4
—
7
45
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
87
789
1.16
0.45
6.7
5.9
ml/min/173m2
114.1
114.9
0.12
54
473
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
93
0.63
0.43
1.0
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
32
1.56
0.42
2.0
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
58
1.38
0.41
2.0
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
23
185
1.26
0.41
2.3
2.1
ng/l
13.2
15.6
—
10
59
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
12
87
1.39
0.41
2.2
1.3
g/l
1.2
1.2
0.05
12
82
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
17
0.00
0.41
0.0
1.9
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
18
0.00
0.40
0.0
2.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
94
1001
0.88
0.39
4.7
4.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
161
1533
1.16
0.39
8.5
9.5
u/l
25.6
24.1
0.39
155
1470
(3051651) Icteric interference index of Serum or Plasma
5
35
1.43
0.39
1.4
4.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
8
111
0.70
0.38
4.5
3.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
96
885
1.13
0.38
2.8
2.0
mmol/l
5.3
5.3
0.19
85
799
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
114
0.68
0.38
2.5
2.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
25
206
1.23
0.37
3.8
3.6
%
24.5
21.3
0.53
25
198
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
188
1814
1.20
0.37
4.4
4.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
9
70
1.29
0.37
8.3
5.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
121
1134
1.13
0.36
7.5
11.0
e9/l
2.5
2.4
0.39
106
941
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
166
0.76
0.36
1.2
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
133
0.73
0.36
1.1
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
123
0.71
0.36
2.1
2.1
—
—
—
0
0
(3000492) Spirometry study
15
116
1.30
0.36
2.3
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
6
42
1.43
0.35
3.0
4.8
umol/l
451.3
440.2
—
6
42
(3006245) CD3-CD19+ cells/100 cells in Blood
11
81
1.36
0.35
7.4
4.8
%
14.8
15.7
0.09
11
81
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
10
73
1.38
0.33
8.0
4.6
%
26.7
27.2
—
10
73
(3007853) Bacteria identified in Skin by Aerobe culture
29
246
1.19
0.33
1.7
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
49
435
1.15
0.33
11.5
12.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
11
82
1.35
0.33
1.3
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
75
802
0.89
0.33
2.4
1.8
g/l
1.5
1.4
0.08
40
390
(3018010) Neutrophils/100 leukocytes in Blood
118
1110
1.12
0.32
7.5
11.0
%
48.9
48.3
0.22
110
1068
(3035933) Granulocytes/100 leukocytes in Blood
7
54
1.29
0.30
1.1
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
7
54
1.29
0.30
2.3
1.1
—
233.4
—
0
17
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
55
1.27
0.30
1.9
4.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
53
576
0.88
0.30
1.8
1.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
21
175
1.21
0.29
4.8
2.5
u/l
5285.0
4684.5
—
7
47
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
65
1.23
0.27
1.4
1.6
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
10
76
1.32
0.27
7.9
4.8
%
67.7
68.3
—
10
76
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
76
1.32
0.27
1.1
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
25
285
0.85
0.27
1.0
1.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
8
66
1.21
0.27
5.1
3.7
mmol/l
1.3
1.2
—
8
56
(3026008) Bacteria identified in Urine by Culture
43
385
1.13
0.26
3.2
2.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
9
71
1.27
0.26
1.3
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
86
1.28
0.25
2.5
2.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
77
1.30
0.25
8.0
4.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
32
282
1.15
0.25
4.5
5.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
80
0.74
0.24
1.0
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
25
282
0.86
0.24
1.7
2.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
36
321
1.13
0.24
5.9
4.1
inr
1.1
1.1
—
7
89
(3051611) Lipemic interference index of Serum or Plasma
5
37
1.35
0.23
1.6
4.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
37
1.35
0.23
2.0
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
37
1.35
0.23
2.2
4.1
%
48.6
49.2
—
5
37
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
37
1.35
0.23
2.2
4.0
e9/l
3.1
3.1
—
5
37
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
53
485
1.11
0.23
2.3
3.5
mg/l
2.6
2.6
0.02
47
428
(3017143) Hepatitis C virus Ab [Presence] in Serum
22
250
0.86
0.23
1.4
1.6
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
38
1.31
0.23
1.2
1.1
%
80.6
75.1
—
5
38
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
38
1.31
0.23
1.2
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
39
1.28
0.23
2.4
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
21
181
1.17
0.21
2.2
2.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
5.6
—
0
10
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
0.4
—
0
5
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
29
257
1.14
0.21
2.4
6.9
mg/l
5.5
2.5
0.42
20
185
(3005011) Chlamydia sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
12
0.00
0.21
0.0
2.8
—
46.8
—
0
6
(3021589) Normoblasts [#/volume] in Blood
112
1067
1.08
0.21
9.1
13.4
e9/l
0.0
0.0
0.49
91
771
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
102.3
—
0
13
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
9
112
0.79
0.20
2.4
2.0
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.6
—
4.9
—
0
14
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
89
1.24
0.20
2.6
2.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
51
1.17
0.19
1.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
57
1.22
0.18
1.1
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
58
1.20
0.18
43.7
24.9
%
76.1
71.2
—
7
58
(3022313) Gas panel - Capillary blood
46
424
1.10
0.18
8.2
9.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
33
299
1.11
0.17
1.4
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
65
0.76
0.17
1.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
65
0.76
0.17
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
57
532
1.08
0.17
1.5
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
68
0.72
0.17
1.2
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
8
72
1.11
0.16
1.4
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
76
0.78
0.16
1.5
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
77
0.77
0.16
1.5
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
89
0.77
0.14
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
15
169
0.87
0.14
1.6
2.4
—
—
—
0
0
(3006598) pH of Arterial cord blood
8
99
0.79
0.14
1.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
28
301
0.91
0.13
1.6
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
17
188
0.89
0.13
2.0
4.2
ng/l
3337.0
1222.7
—
10
116
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
84
1.19
0.13
1.4
2.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
50
471
1.07
0.12
13.9
11.8
mmol/l
0.5
0.9
0.42
39
373
(3031040) Bacteria [#/volume] in Urine by Automated count
95
970
0.95
0.12
5.1
3.8
e6/l
35.8
132.5
—
5
13
(3005719) IgG [Mass/volume] in Serum or Plasma
25
230
1.09
0.10
5.4
5.3
g/l
8.5
8.6
0.02
25
222
(36304419) Bacteria [Presence] in Urine
53
547
0.95
0.09
4.2
4.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
33
346
0.94
0.09
1.6
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
34
356
0.94
0.09
3.3
4.2
e6/l
2.9
2.4
0.20
20
210
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
48
1.03
0.09
1.0
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
5
48
1.03
0.09
1.6
1.4
ug/g
396.8
328.1
—
5
27
(3019225) pH of Specimen
6
53
1.13
0.09
1.7
4.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
53
1.13
0.09
1.3
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
53
1.13
0.09
1.3
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
53
1.13
0.09
1.3
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
53
1.13
0.09
1.3
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
55
1.08
0.09
1.2
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
91
880
1.04
0.08
3.4
3.4
ug/l
51.4
52.2
0.03
85
829
(3002256) Pathology report gross observation
10
112
0.88
0.08
1.0
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
36
375
0.94
0.08
3.1
3.3
mosm/kgh2o
560.9
608.7
0.69
28
321
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
48
457
1.05
0.08
2.2
2.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
63
1.10
0.08
2.1
2.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
63
1.10
0.08
1.6
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
112
1089
1.04
0.08
4.6
4.4
mm/h
7.0
7.4
0.22
104
1008
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
68
1.02
0.08
1.6
2.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
68
1.02
0.08
1.0
6.8
—
—
—
0
0
(44790049)
8
74
1.07
0.07
3.1
2.3
—
—
—
0
0
(44806118)
8
74
1.07
0.07
3.1
2.3
—
—
—
0
0
(44790047)
8
74
1.07
0.07
3.1
2.3
—
—
—
0
0
(44790048)
8
74
1.07
0.07
3.1
2.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
8
75
1.06
0.07
2.5
2.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
81
822
0.96
0.07
3.3
2.6
mmol/l
2.7
2.6
0.63
75
772
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
86
1.04
0.07
1.4
2.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
19
176
1.08
0.06
1.1
1.2
u/ml
0.4
0.9
0.56
13
134
(3000850) Epithelial cells [#/volume] in Urine
40
382
1.05
0.06
4.5
3.4
e6/l
6.7
7.7
0.18
32
330
(3017181) Myelocytes/100 leukocytes in Blood
11
99
1.11
0.05
3.3
6.1
%
0.6
0.5
—
5
33
(3041096) Erythrocytes [Presence] in Urine by Automated
33
314
1.05
0.05
4.3
2.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
12
109
1.10
0.05
1.4
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
81
818
0.97
0.05
3.2
2.6
mmol/l
1.3
1.4
1.05
76
771
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
47
478
0.97
0.04
2.4
2.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
22
228
0.95
0.03
1.9
1.4
titre
192.0
603.6
—
5
33
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
15
157
0.94
0.03
1.0
1.1
u/ml
2.6
11.1
—
6
47
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
55
535
1.03
0.03
15.9
15.1
mmol/l
24.7
24.9
0.23
55
535
(40768797) Stomach Pathology biopsy report
13
121
1.07
0.02
1.8
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
54
545
0.98
0.02
4.1
4.6
e6/l
0.2
0.3
0.37
41
407
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
34
346
0.97
0.02
3.7
4.2
e6/l
2.3
0.9
0.55
20
199
(3023520) Reticulocytes [#/volume] in Blood
21
200
1.05
0.02
3.2
5.8
e9/l
64.6
59.0
0.26
11
123
(3018095) Leukocytes [#/volume] in Urine
68
683
0.98
0.02
5.8
5.4
e6/l
110.5
56.9
0.38
47
454
(3021879) Hepatitis B virus core Ab [Presence] in Serum
15
142
1.05
0.01
1.2
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
60
602
0.98
0.01
3.4
2.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
84
840
0.99
0.01
3.7
2.8
mmol/l
4.3
4.3
0.16
79
800
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
20
192
1.04
0.01
1.1
1.3
u/ml
0.1
3.5
3.55
14
128
(36660697) Celiac disease serology panel - Serum
37
373
0.98
0.00
1.4
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
14
140
0.99
0.00
1.1
1.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
13
130
0.99
0.00
1.5
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
33
327
1.00
0.00
2.0
2.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
14
144
0.96
0.00
2.3
2.8
u/l
24.6
31.6
0.54
14
118
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
125
1.03
0.00
1.4
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
15
150
0.99
0.00
1.5
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
59
585
1.00
0.00
4.8
4.6
e6/l
25.4
27.6
0.08
46
443
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
19
188
1.00
0.00
3.4
12.6
%
87.3
91.4
0.35
19
188
(3045414) Leukocytes [Presence] in Urine
5
49
1.01
0.00
1.4
1.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
879.4
—
0
9
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4146454)
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
5
0.00
0.00
0.0
5.2
—
12.0
—
0
5
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009410) PHENobarbital [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
14.3
—
92.6
—
0
7
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
7
72
0.96
0.00
1.0
6.5
mg/l
294.3
418.2
—
7
72
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
61
605
1.00
0.00
5.7
4.9
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
20.2
—
30.6
—
0
5
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
3.8
—
4.1
—
0
5
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
7
0.00
0.00
0.0
1.4
—
12.8
—
0
7
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
61.9
—
0
8
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(4024509)
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
98
0.91
0.00
1.3
1.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
50
0.99
0.00
1.0
1.2
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
6
0.00
0.00
0.0
4.8
—
0.2
—
0
6
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
32.8
—
0
9
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
2000.0
—
0
5
(3034426) Prothrombin time (PT)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
54.6
—
0
5
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032641) Amino acids panel - Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
11.5
—
0
8
(3016018) Differential panel - Cerebral spinal fluid
5
51
0.97
0.00
1.0
5.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
63
0.94
0.00
1.0
6.9
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
88.3
—
0
8
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
4.3
—
25.0
—
0
6
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
5
0.00
0.00
0.0
20.0
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
60
0.99
0.00
1.5
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
5
0.00
0.00
0.0
5.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
59
1.01
0.00
1.5
2.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_SLOW_FETAL_GROWTH_FETAL_MALNUTRITION and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| P16_SLOW_FETAL_GROWTH_FETAL_MALNUTRITION | 6.474 [4.98, 8.41] | < 0.001 |
| Birth year | 0.997 [0.99, 1.0] | 0.407 |
During the follow-up period (1.1.1998 — 31.12.2019), 71 out of 6317 females with P16_SLOW_FETAL_GROWTH_FETAL_MALNUTRITION died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| P16_SLOW_FETAL_GROWTH_FETAL_MALNUTRITION | 3.741 [2.92, 4.79] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 69 out of 5727 males with P16_SLOW_FETAL_GROWTH_FETAL_MALNUTRITION died.
Mortality risk
Mortality risk for people of age
years, who have P16_SLOW_FETAL_GROWTH_FETAL_MALNUTRITION.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.569% | 0.49% |
| 5 | 3.842% | 3.819% |
| 10 | 8.574% | 10.069% |
| 15 | 17.236% | 18.695% |
| 20 | 30.123% | 31.154% |
Relationships between endpoints
↥Index endpoint: P16_SLOW_FETAL_GROWTH_FETAL_MALNUTRITION – Slow fetal growth and fetal malnutrition
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data